Doctors Prescribe Elmiron To Men That Suffer From A Painful Condition Similar To A Woman's Bladder Pain

Nonbacterial prostatitis affects men with chronic prostate gland pain and is treated With Elmiron

Sunday, September 19, 2021 - Most research reporting on Elmiron eye problems focus on women that develop the condition after childbirth. Many of the lawsuits that accuse Janssen Pharmaceuticals of failing to warn about Elmiron's side effects are women with interstitial cystitis (IC), better known as painful bladder syndrome, a condition they were treating with prescription Elmiron. Men suffer from a similar condition called non-bacterial prostatitis (NBP), also known as chronic pelvic pain syndrome. NBP causes chronic pain for middle-aged men who are at risk of developing prostate cancer. The ADA reports on the condition. "Nonbacterial prostatitis is a condition in which there is persistent pain in the area around the prostate gland. This condition is also sometimes called chronic (long-lasting) prostatitis or chronic pelvic pain syndrome." The pain may or may not be caused by the prostate gland which is a small gland that sits just below the bladder. The ADA lists the signs men should watch for that could indicate they have the condition. Early signs of NBP are: "Pain in the area between the scrotum and anus, pain when ejaculating, and blood in the urine or semen. An unacceptably high percentage of men and women (approximately 1 out of 4 according to the Kaiser Permanente study) that have taken Elmiron report they have experienced eyesight deterioration. Science Daily wrote an article exploring the situation titled, More evidence linking common bladder medication to a vision-threatening eye condition - New study shows about a quarter of patients with significant exposure to the drug show signs of retinal damage" Elmiron vision loss is thought to continue permanently.

Men that have been diagnosed with NBP and have been prescribed Elmiron have developed pigmentary maculopathy and have experience progressive, irreversible night blindness from taking the drug. Men and women are filing Elmiron eye lawsuits against Janssen Pharmaceuticals and also their parent company Johnson & Johnson for failing to warn them of blindness side effects of the drug for more than 20 years after beginning selling Elmiron in 1996. The OrthoElmiron website now gives details about the drug's dangers. The company warns users not to take more of the drug than prescribed as it is believed doing so could cause their macula to degenerate at an accelerated rate. Millions of Elmiron prescriptions have been written and filled by doctors and pharmacists that were left in the dark about the night blindness side effects of the drug. Elmiron eyesight damage is diagnosed by comparing eye tests over time and recording the changes to the retina, the light-sensing area in the back of the eye responsible for clear vision to the central part of the eye. Long-term use of Elmiron causes spots to occur and grow in size over time that block light causing difficulty seeing in less than optimal lighting conditions and difficulty seeing while driving at night.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.